Miller Howard Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,954
Closed -$652K 172
2024
Q3
$652K Sell
1,954
-1
-0.1% -$380 0.02% 143
2024
Q2
$805K Sell
1,955
-1,139
-37% -$451K 0.03% 131
2024
Q1
$1.25M Buy
3,094
+19
+0.6% +$6.68K 0.04% 129
2023
Q4
$943K Buy
3,075
+39
+1% +$10.5K 0.03% 136
2023
Q3
$735K Sell
3,036
-6
-0.2% -$1.53K 0.03% 135
2023
Q2
$731K Buy
3,042
+19
+0.6% +$3.95K 0.03% 140
2023
Q1
$568K Buy
3,023
+31
+1% +$6.41K 0.02% 145
2022
Q4
$636K Buy
2,992
+2
+0.1% +$400 0.02% 144
2022
Q3
$470K Buy
2,990
+8
+0.3% +$1.28K 0.02% 148
2022
Q2
$446K Buy
+2,982
New +$432K 0.02% 153

Other funds holding MEDP

Miller Howard Investments's MEDP Position: Q4 2024 in Review

Miller Howard Investments sold out of Medpace (MEDP) in Q4 2024, closing a stake of 1,954 shares — an estimated $652K sold.

Miller Howard Investments first reported a position in MEDP in Q2 2022 and held it in 10 quarters. The position peaked at $1.25M in Q1 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Miller Howard Investments reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Miller Howard Investments sold 1,954 Medpace shares in Q4 2024, an estimated $652K.
  • Miller Howard Investments first reported a position in Medpace in Q2 2022 and held it in 10 quarters.
  • Miller Howard Investments's Medpace position peaked at $1.25M in Q1 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Miller Howard Investments's 13F filing for Q4 2024, filed 28 Jan 2025.